Aetna, Humana settle fines for information breach, coverage gaps

Two major healthcare insurers, Aetna and Humana, are set to dole out hundreds of thousands of dollars to settle separate disputes over health information disclosures and inadequate network coverage.

In New Jersey, Aetna, the nation’s third largest health insurance provider, has agreed to pay a $365,000 fine for violating the privacy of thousands of policyholders in two separate mailings, the Associated Press reported.

Aetna reportedly revealed the HIV status of 12,000 patients in several states in 2017, including more than 600 in New Jersey. The company mailed to policyholders information on how to purchase HIV medication in envelopes with a clear window that made the sensitive information visible. Aetna settled a lawsuit over the breach of information for $17 million in January.

In September this year, the company sent a mailing to 1,600 people in envelopes that stated the name and logo of a study for a heart condition. The action affected more than 180 people living in New Jersey. Aetna told the AP it is implementing new measures to prevent similar information breaches.

The settlement comes just as Aetna is preparing to merge with CVS Health in a $69 billion that was approved by the Department of Justice last week.

Separately, Humana will pay $700,000 to the Texas Department of Insurance for providing inadequate coverage in Harris, Bexar and Travis counties, according to the agency. Consumers couldn’t receive in-network coverage for anesthesia services at more than 20 hospitals and surgical centers in three of the state’s largest metro areas due to an inadequate number of anesthesiologists.

Humana was contacted by TDI after canceling network contracts for anesthesiology services, and the company agreed to take immediate corrective actions to reprocess bill so consumers did not face higher costs as a result of inadequate networks.

Health plans operating in Texas are required to file annual network adequacy reports with the agency and notify TDI and consumers about any coverage gaps. Humana’s reports to TDI did not adequately or timely disclose the issue to the agency or consumers, according to TDI.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.